We came across a bullish thesis on BioMarin Pharmaceutical Inc. on Value investing subreddit by BearWithMeGM. In this article, we will summarize the bulls’ thesis on BMRN. BioMarin Pharmaceutical Inc.

Aristotle Capital Boston, LLC, an investment advisor, released its “Small Cap Equity Fund” third-quarter 2025 investor letter ...

Earlier on December 8, Barclays initiated coverage of GoodRx with an Underweight rating and $3 price target. This decision ...

Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Dec. 19, 2025 /CNW/ — USA News Group News Commentary – The recent FDA approval in November of the first bispecific antibody combination for ...

LSL PHARMA GROUP INC. (TSXV: LSL) (The “Corporation” or ” LSL Pharma”), a Canadian integrated pharmaceutical company, is ...

The Federal Reserve has officially shifted gears. By lowering interest rates in mid-December 2025, the Fed sent a decisive ...

From an investment perspective, Propanc offers a striking contrast to the high-valuation tech stocks now under rotation pressure. With a market capitalization under $15 million, it trades at a ...

The global Orthobiologics Market, valued at $5.4 billion in 2021, is expected to grow at a rate of 7% annually through 2026. This growth is driven by factors such as an increasing number of sports ...

According to Mordor Intelligence, the healthcare IT market is valued at USD 413.14 billion in 2025, and is projected to surpass USD 839.67 billion by 2030, at a CAGR of 15.24% during the forecast ...

A Bloomberg News analysis shows that less than half of the companies in the S&P 500 index received analyst questions about ...

By source, soybean oil is anticipated to hold 47.5% of the total revenue share in 2025, positioning it as the leading raw ...